Atrimed Pharma plant science receives breakthrough in molecule research for COVID-19 cure

▴ atrimed-pharma-plant-science-receives-icmr-approved-breakthrough-molecule-research-covid19-cure
Efforts to begin human/clinical trial on the oral drug for COVID-19

Bangalore based Atrimed Pharmaceuticals, a pioneer in developing scientifically tested Plant-based medication, announced that, three of our samples tested positive against SARS-CoV-2 in the ICMR (Indian Council for Medical Research) designated laboratory and the developed drug will be available as an oral medicine. Company Leverages Proven Antiviral and Plant-based medicinal expertise to evaluate the new approaches for treating the Novel Coronavirus Disease COVID-19. The pharma company is dedicated to develop a Phyto molecule drugs for viral infections and other diseases, today takes pride that it has initiated a program to discover drug candidates for the treatment of patients infected with the novel coronavirus COVID-19, also known as SARS-CoV-2.

Commenting on the exclusive breakthrough Dr Hrishikesh Damle MD & CEO stated, “Based on our proven track record in virology and our capabilities in rare diseases, we believe our core competencies position us well to discover a potential treatment for COVID-19, and we are delighted to establish that three molecules out of ten submitted are passed the test and ready for Human/Clinical Trial for developing drug for the treatment of Coronavirus.”

He further added that these molecules were ready for scientific research in the month of March 2020 itself but took so long for clearance. “Our decision to initiate a drug discovery for COVID-19 is a natural evolution of our work and mission. Regional Centre for Biotechnology has recognised and approved 3 effective plant molecules against COVID-19 and further studies will begin shortly."

The Drug Discovery and Development Process passes through various stages which begins with Target Selection leading to discovery wherein high throughput screening paves for chemical synthesis and then prepares for Vitro/Behavioural Studies and finally for Clinical/Human trial, and it is great achievement for Atrimed to take their research to their drug development to the next level.

The company develops medicines from plant-based molecules to develop drugs that cure diseases that have plagued humanity such as Psoriasis, Acne, Arthritis and more. It combines the traditional cures with the knowledge base created from computer-aided drug design, biotechnology and Artificial Intelligence to establish a library of plant molecules, some 400,000 strong, the largest in the world. Its products cater to Skin and Haircare, Mother and Child care, and Bone related diseases, Nutrition, Metabolism and Allergies. The pharmaceutical company was sent to BIO 2019, Philadelphia, USA which is the largest Biotechnology Expo in the world by the Karnataka Government to showcase Karnataka’s biotechnological ecosystem to learn more about the perspectives of high-level government officials, key thought leaders and experts from around the world on the new opportunities and challenges facing the global biotech industry.

Tags : #AtrimedPharmaceuticals #COVID-19Cure #DrHrishikeshDamle #ICMR #KarnatakaGovernment

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Behind the success of every working woman, there are many working women: Neha Dhupia, Beauty Pageant, Model and Bollywood ActressDecember 11, 2023
Universal Health Care: India races against time; experts call for scaling up both Infrastructure and Delivery SystemDecember 11, 2023
China Doctors Remove Live Worms from Woman’s Eyes HealthCare December 11, 2023
Immunity Boosting Measures for Optimal Health during WinterDecember 11, 2023
How to Save Gaza’ Catastrophic For HealthCareDecember 11, 2023
Broccoli Important For Our Health December 11, 2023
Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
Are online spaces safe for women?December 08, 2023
Value 360 Communications to drive Xynteo's public relations strategy, focusing on strategic communications and media relations in IndiaDecember 07, 2023
Ayurveda is an ancient science for modern times: Dr T.S. Prasad, Ayush Integrated Wellness Center, NIMSDecember 07, 2023
Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Shiprocket aims to contribute to a thriving ecosystem of Indian eCommerce businesses by disbursing funds worth INR 100 Cr to SMBs in the next 12 monthsDecember 06, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023